Cereno Scientific - About the company
Cereno Scientific is a public company based in Askim (Sweden), founded in 2012. It operates as a Developer of therapeutics for cardiovascular diseases. Cereno Scientific has raised an undisclosed amount in funding. The company has 409 active competitors, including 126 funded and 111 that have exited. Its top competitors include companies like argenx, Tenaya Therapeutics and Vor Biopharma.
Company Details
Developer of therapeutics for cardiovascular diseases. It offers a lead candidate CS a well-tolerated oral therapy for pulmonary arterial hypertension, CS014 for idiopathic pulmonary fibrosis, and CS585 an oral, highly potent and selective prostacyclin receptor agonist for pulmonary hypertension.
- Website
- cerenoscientific.com
- Email ID
- *****@cerenoscientific.com
- Phone Number
- +46 **********
Key Metrics
Founded Year
2012
Location
Askim, Sweden
Stage
Public
Latest Funding Round
Ranked
69th among 409 active competitors
Employee Count
33 as on Sep 30, 2026
Similar Companies
Exit Details
Public
Cereno Scientific's IPO details
Cereno Scientific got listed on Jun 16, 2023.
Click here to take a look at Cereno Scientific's IPO in detail
Sign up to download Cereno Scientific's company profile
Cereno Scientific's funding and investors
Cereno Scientific has raised funding over 1 round. Cereno Scientific has 2 institutional investors.
Here is the list of recent funding rounds of Cereno Scientific:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 28, 2025 | 5763612 | Post IPO | 5305034 | 5839521 | 1507297 | 8964327 |
View details of Cereno Scientific's funding rounds and investors
Cereno Scientific's founders and board of directors
Founder? Claim ProfileCereno Scientific's employee count trend
Cereno Scientific has 33 employees as of Sep 26. Here is Cereno Scientific's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Cereno Scientific's Competitors and alternates
Top competitors of Cereno Scientific include argenx, Tenaya Therapeutics and Vor Biopharma. Here is the list of Top 10 competitors of Cereno Scientific, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of antibody-based drugs to treat autoimmune diseases and cancer | $61.9M | 75/100 | ||
2nd | Tenaya Therapeutics 2016, San Francisco (United States), Public | Developer of regenerative and gene therapeutics for heart failure | $248M | 70/100 | |
3rd | Vor Biopharma 2019, Cambridge (United States), Public | Developer of therapeutics to treat acute myeloid leukemia | $152M | 68/100 | |
4th | 4D Molecular Therapeutics 2013, Emeryville (United States), Public | Developer of gene therapeutics for genetic disorders | $187M | 67/100 | |
5th | Kiniksa Pharmaceuticals 2015, Lexington (United States), Public | Developer of therapeutics for multiple diseases treatment | $320M | 66/100 | |
6th | PureTech Health 2005, Boston (United States), Public | Developer of immunotherapeutics for multiple diseases | $107M | 66/100 | |
7th | Ventyx Biosciences 2018, Encinitas (United States), Acquired | Developer of therapeutics to treat autoimmune diseases | $165M | 66/100 | |
8th | Esperion Therapeutics 1998, Ann Arbor (United States), Acquired | Developer of lipoprotein cholesterol (LDL-C) lowering therapies | $107M | 66/100 | |
9th | Structure 2017, San Francisco (United States), Public | Developer of oral small molecule drugs for chronic diseases | $191M | 65/100 | |
10th | Cellino 2017, Cambridge (United States), Series A | Developer of autologous cell therapies | $125M | 65/100 | |
69th | Cereno Scientific 2012, Askim (Sweden), Public | Developer of therapeutics for cardiovascular diseases | - | 50/100 |
Looking for more details on Cereno Scientific's competitors? Click here to see the top ones
Cereno Scientific's Investments and acquisitions
Cereno Scientific has made no investments or acquisitions yet.
Reports related to Cereno Scientific
Here is the latest report on Cereno Scientific's sector:
News related to Cereno Scientific
Media has covered Cereno Scientific for a total of 17 events in the last 1 year, 7 of them have been about company updates.
•
Cereno Scientific Activates First Clinical Site in Global Phase IIb EPIMODE Trial of CS1 in PAH, Enabling Patient RecruitmentStock Screener•Aug 13, 2026•Cereno Scientific
•
Cereno Scientific raises SEK 60 million at a premium ahead of next phaseBioStock - Connecting Innovation and•Jun 30, 2026•Cereno Scientific
•
Cereno Scientific to Participate at Nordic Health Summit Japan and ChinaBio Partnering ForumCision•Apr 10, 2026•Cereno Scientific
•
Cereno Scientific Receives Approval for FDA-aligned Phase I Study of CS014Cision•Mar 17, 2026•Cereno Scientific
•
•
•
Cereno Scientific Provides Update on Expanded Access Program for CS1Cision•Feb 03, 2026•Cereno Scientific
•
Cereno Scientific Announces First Peer-Reviewed Publication on HDAC Inhibitor CS014PR Newswire•Jan 14, 2026•Cereno Scientific
•
Cereno Scientific Receives approximately SEK 5 million Through Exercise of 728,957 Warrants by Arena Investors, LPCision•Jan 08, 2026•Cereno Scientific, Arena Investors
•
Cereno Scientific's Board and Management Enter Lock-up AgreementsCision•Dec 18, 2025•Cereno Scientific
Are you a Founder ?
FAQs about Cereno Scientific
Explore our recently published companies
- Spomlek - Poland based, Unfunded company
- More Tattoo Clients - Unfunded company
- Swallace Marketing - Unfunded company
- Sunset Salon Suites - Sunset Beach based, Unfunded company
- Tailgate Motor - Fremont based, 2016 founded, Unfunded company
- Art Of Survival - Unfunded company